Medical/Pharmaceuticals

HSA approves GSK's Arexvy, the world's first respiratory syncytial virus (RSV) vaccine for older adults [1]

* Arexvy has been approved by the Health Sciences Authority (HSA) of Singapore for active immunisation for the prevention of lower respiratory tract disease (LRTD) caused by respiratory syncytial virus (RSV) in individuals 60 years of age and older.[2] * Arexvy is 94.6% efficacious in prevent...

2024-05-16 10:00 3052

BAXTER ANNOUNCES MISSION AND LOGO FOR PROPOSED KIDNEY CARE COMPANY VANTIVE

DEERFIELD, Ill., May 16, 2024 /PRNewswire/ -- Baxter International Inc. (NYSE:BAX), a global medtech leader, announced today the mission and logo for its proposed kidney care and acute therapies company, to be namedVantive

2024-05-16 09:56 2634

EHA 2024 | Results from Five Studies of Ascentage Pharma's Key Drug Candidates Selected for Presentations at 2024 European Hematology Association Hybrid Congress

SUZHOU, China and ROCKVILLE, Md., May 15, 2024 /PRNewswire/ -- Ascentage Pharma (6855.HK), a global biopharmaceutical company engaged in developing novel therapies for cancer, chronic hepatitis B (CHB), and age-related diseases, announced today that the latest results from five studies have been ...

2024-05-16 09:03 2564

Nobel Laureate Jules Hoffmann's Team Collaborates with Infinitus on Advances in Polysaccharides and Immunity

GUANGZHOU, China, May 16, 2024 /PRNewswire/ -- Recently, Professor Jean-Luc, Director of the Institute of Molecular Cell Biology at the French National Centre for Scientific Research (CNRS), Member of the Infinitus Global Scientific Advisory Board, and Principal Investigator of Hoffmann Infinitus...

2024-05-16 02:02 3969

LoRaWAN® Temperature and Humidity Sensors for Food Safety, Pharmaceutical and Beyond

XIAMEN, China, May 15, 2024 /PRNewswire/ -- In industries like pharmaceuticals, food, and logistics, maintaining the integrity of products throughout the supply chain is critical. Temperature and humidity are two key parameters that can significantly affect the quality and safety of goods, especi...

2024-05-15 23:05 2633

Ractigen Therapeutics Receives IND Approval from China's NMPA to Initiate Phase 1 Clinical Trials for RAG-17 in SOD1-ALS Patients

SUZHOU, China, May 15, 2024 /PRNewswire/ -- Ractigen Therapeutics, a clinical-stage pharmaceutical company committed to developing pioneering therapies, today announces that the Center for Drug Evaluation (CDE) ofChina's National Medical Products Administration (NMPA) has approved the Investigat...

2024-05-15 20:00 2203

Center for Treatment of Paralysis and Reconstructive Nerve Surgery at Hackensack Meridian Jersey Shore University Medical Center Awarded Global Healthcare Accreditation

The Center is the first GHA accredited facility in New Jersey. MIAMI, May 15, 2024 /PRNewswire/ -- Hackensack Meridian Jersey Shore University Medical Center, located in Neptune, New Jersey, celebrates a significant milestone: the attainment of Global Healthcare Accreditation (GHA)  for Medical T...

2024-05-15 18:00 2628

Leading Penang-based Healthcare Provider Bags Multiple Awards at the GlobalHealth Asia-Pacific Awards 2024

PENANG, Malaysia, May 15, 2024 /PRNewswire/ -- Island Hospital swept five awards at the GlobalHealth Asia-Pacific Awards 2024 recently. Among these are the Standout Jury Award for Hospital of the Year inAsia-Pacific and Most Sustainable Healthcare Institution of the Year inAsia-Pacific, cementing...

2024-05-15 14:45 2580

Renowned Wellness Expert Dr Jitendra Pokhriyal Returns to The Westin Resort Nusa Dua, Bali as Wellness Ambassador

BALI, Indonesia, May 15, 2024 /PRNewswire/ -- The Westin Resort Nusa Dua, Bali  is delighted to welcome backDr Jitendra Pokhriyal as their Wellness Ambassador after a four-year hiatus. Dr Jitendra, originally from the Himalayas inIndia, previously served ...

2024-05-15 10:00 3145

Getinge's financial target 2024-2028: Adjusted EPS growth of above 12% on average

GOTHENBURG, Sweden, May 15, 2024 /PRNewswire/ -- Getinge updates its financial target for adjusted EPS growth 2024-2028 to be above 12% on average. The target takes into account today's decisions (see below) that follow from the letter that the U.S. Food and Drug Administration (FDA) sent to heal...

2024-05-15 02:52 2513

Everest Medicines Announces Commercial Launch and First Prescription for NEFECON® in Mainland China

SHANGHAI, May 14, 2024 /PRNewswire/ -- Everest Medicines (HKEX 1952.HK, "Everest", or the "Company"), a biopharmaceutical company focused on the discovery, clinical development, manufacturing and commercialization of innovative medicines and vaccines, today announced that NEFECON®, a delayed rel...

2024-05-14 21:41 3362

HealthTech Bioactives Partners with Abolis for Sustainable Production of High-Value Polyphenols

PARIS, May 14, 2024 /PRNewswire/ -- HealthTech Bioactives (HTBA) has chosen Abolis as their partner to develop strains to produce valuable polyphenols, addressing supply chain challenges and driving innovation in the industry. Founded in 2019, after 40 years' experience under different ownership,...

2024-05-14 20:00 2732

Novosis Putty Sets the Stage for U.S. Market Success with Promising Clinical Results

SEOUL, South Korea, May 14, 2024 /PRNewswire/ -- CGBio, a leading medical device company, announced a significant clinical results demonstrating a 100% interbody fusion success rate at 52 weeks for its innovative bone substitutes, "Novosis" and "Excelos Inject," which have been published in the '...

2024-05-14 20:00 2759

HUB Organoids B.V. Awarded Frost & Sullivan's 2024 Technology Innovation Leadership Award for Transforming Drug Development with Highly Advanced Organoid Technology

HUB Organoids Holdings B.V. revolutionizes pre-clinical and clinical drug development through its cutting-edge organoid technology, enhancing its accuracy and efficiency. SAN ANTONIO, May 14, 2024 /PRNewswire/ -- Frost & Sullivan recently researched the organoids landscape and, based on its find...

2024-05-14 20:00 2170

Pantai Hospital Kuala Lumpur Continues Legacy of Care with Community Health Screening for the Lembah Pantai Community

KUALA LUMPUR, Malaysia, May 14, 2024 /PRNewswire/ -- Pantai Hospital Kuala Lumpur, together with Premier Integrated Labs, Pantai Integrated Rehab, and Twin Tower Medical Centre, and with support from the Breast Cancer Welfare Association Malaysia and AstraZeneca, marked a milestone in their conti...

2024-05-14 19:41 2471

OrthAlign Launches Lantern® Handheld Technology for Total, Partial, and Revision Knee Arthroplasty in Japan.

IRVINE, Calif., May 14, 2024 /PRNewswire/ -- OrthAlign, Inc., a leading innovator in surgical technology, announces the launch of its flagship product, Lantern, inJapan. The launch will be driven by its longstanding commercial partner, who have represented OrthAlign in the market since 2013 and s...

2024-05-14 08:00 2552

Brii Biosciences Announces Two Breakthrough Therapy Designations for BRII-877 and BRII-835 Building on Extensive Clinical Evidence from Multiple Phase 2 Studies

DURHAM, N.C. and BEIJING, May 14, 2024 /PRNewswire/ -- Brii Biosciences Limited ("Brii Bio" or the "Company", stock code: 2137.HK), a biotechnology company developing therapies to improve patient health and choice across diseases with high unmet need, today announced tha...

2024-05-14 07:27 3921

Mabwell Announces Clinical Trial Progress of 9MW2821 in Triple-Negative Breast Cancer

SHANGHAI, May 13, 2024 /PRNewswire/ -- Mabwell (688062.SH), an innovation-driven biopharmaceutical company with entire industry chain, announced the progress of the clinical study of its novel Nectin-4-targeting ADC (R&D code: 9MW2821) for triple-negative breast cancer. Based on 9MW2821's curren...

2024-05-13 22:00 2404

ObeEnd - Pioneering Drug-Free Weight Management Wristband

VANCOUVER, BC, May 13, 2024 /PRNewswire/ -- WAT Medical, a leader in innovative healthcare solutions, announces the development of ObeEnd, the world's first weight management wristband backed by clinical evidence showcasing its efficacy in reducing dietary intake. Findings from this groundbreakin...

2024-05-13 21:00 2311

BGI-HL OHA Lab inaugurated in Harbin, initiating colorectal cancer risk assessment for 800,000

SHENZHEN, China, May 13, 2024 /PRNewswire/ -- On May 10, 2024, the BGI-Heilongjiang Omics Health Axis Intelligent Laboratory (BGI-HL OHA Intelligent Laboratory) was inaugurated inHarbin, Heilongjiang province, China, marking a significant advance in the province's efforts to address public healt...

2024-05-13 13:34 3247
1 ... 233234235236237238239 ... 646